Cline Christopher R. sold TVTX
April 15, 2026 · Form 4 insider transaction
Cline Christopher R. sold 1,014 shares of Travere Therapeutics, Inc. at $42.61 per share, a transaction worth $43.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,014
Price
$42.61
Total value
$43.2K
InsiderCline Christopher R.
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateApril 15, 2026
Filing dateApril 15, 2026
Shares owned after116,899
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This sale was made pursuant to a written plan adopted on May 28, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of performance restricted stock units.